WHEAT RIDGE, Colo. -- GeneThera said it will begin live animal testing with a leading Mexican university as part of the path to commercializing a live animal test for several veterinary diseases, including mad cow disease.

The company said a scientific department of the university that has been doing ongoing research into Johne's disease (paratuberculosis) initiated the collaboration.

Tony Milici, CEO of GeneThera, said, "The recent press release we put out stating we have commenced operations within Mexico has brought forth a tremendous amount of interest from parties within Mexico. We are thrilled that this university has sought to establish a collaborative facility to further both GeneThera's and the research of the Mexican academic community working on TSE testing."

Sergio Gonzalez, partner in GeneThera's new joint venture in Mexico, said, "I am very pleased to have been able to bring GeneThera and its outstanding scientific work to the attention of this university. I believe a collaboration of this sort between Dr. Milici and our brightest research minds will quickly lead to further results in the field of Johne's testing."

Johne's (pronounced "Yo-nees") disease is a contagious bacterial disease of the intestinal tract. The disease is also called paratuberculosis.

Johne's disease occurs in a wide variety of animals, but most often in ruminants such as cattle, sheep, goats, deer, antelope and bison. Johne's disease has been reported in all of these animals, but is most commonly seen in dairy cattle.

GeneThera did not name the university or its location in the news release.

GeneThera Inc. is a molecular biotechnology company located in Wheat Ridge, Colo. The company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the healthcare industry. The company's proprietary genetic expression assay -- GEA(TM) -- is designed for a host of individual diseases, the current priority being mad cow disease; chronic wasting disease, a disease affecting elk and deer in North America; E.Coli 0157:H7; and Johne's Disease.

SOURCE: GeneThera Inc. via Business Wire.